海克替啶

C₂₁H₄₅N₃

339.60

MFCD00010428

329815112

NA.24

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Involved in studies:

• To identify pure liquid salt forms of aspirin
• Of alkyl based selective displacers for protein purification via ion exchange chromatography
• Of the in vivo application of models for testing drugs against nonreplicating Mycobacterium tuberculosis
• Nutrient-sensitized screening for drugs that shift the energy metabolism from mitochondrial respiration to glycolysis
• Inhibition of angiogensis
• Screening antimalarial drugs

Please find SDS provided by EDQM here..

Sales restrictions may apply.

pharmaceutical primary standard

EDQM

n20/D 1.4649 (lit.)

160 ℃/0.4 mmHg (lit.)

0.889 g/mL at 25 ℃ (lit.)

pharmaceutical (small molecule)

neat

2-8℃

CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1

1S/C21H45N3/c1-6-10-12-19(8-3)14-23-16-21(5,22)17-24(18-23)15-20(9-4)13-11-7-2/h19-20H,6-18,22H2,1-5H3

DTOUUUZOYKYHEP-UHFFFAOYSA-N

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

GHS07

Warning

H315 - H319 - H335

P261 - P264 - P280 - P280 - P304 + P340 + P312 - P337 + P313

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Respiratory system

13 - Non Combustible Solids

WGK 3

158.0 °F - closed cup

70 ℃ - closed cup